New Delhi, January 12, 2026 – Rodec Pharma Limited has filed its Draft Red Herring Prospectus for an initial public offering, marking its entry into the primary market through a 100 percent book-built issue. The proposed public issue is entirely an offer for sale of up to 56.50 lakh equity shares with a face value of ₹10 each, to be divested by promoter and managing director Mukesh Kumar Gupta.The equity shares are proposed to be listed on the BSE and NSE, with the designated exchange to be finalised closer to the offer opening. The company has already received in-principle approvals for listing on both exchanges.IPO Structure and Offer Details
The IPO does not include a fresh issue component. As a result, Rodec Pharma will not...